1.Unsolved Issues in Managing Benign Prostatic Hyperplasia.
Korean Journal of Urology 2013;54(6):349-350
No abstract available.
Prostatic Hyperplasia
2.Juvenile Benign Prostatic Hyperplasia: A Case Report.
Cheon Jin PARK ; Jun Seong JEON ; Won Taek LIM ; George M FARROW ; Jae Mann SONG
Korean Journal of Urology 1994;35(9):1023-1026
No abstract available.
Prostatic Hyperplasia*
3.Pathophysiology of Benign Prostatic Hyperplasia and Significance of Pressure Flow Study.
Journal of the Korean Continence Society 1997;1(1):10-10
No abstract available.
Prostatic Hyperplasia*
4.Differences in Expression of bcl-2 and p53 Protein in Prostate Carcinoma and Benigh Prostate Hyperplasia.
Byung Tae LEE ; Choal Hee PARK ; Kwan Kyu PARK
Korean Journal of Urology 1998;39(7):656-661
No abstract available.
Hyperplasia*
;
Prostate*
;
Prostatic Hyperplasia
;
Prostatic Neoplasms
5.Evaluation the results of treatment the benign prostatic hyperplasia by traditional medication "Than khi hoan gia giam"
Journal of Practical Medicine 2004;483(7):54-56
The study was made on 42 benign prostatic hyperplasia patients. The results showed that after one month therapy by traditional medication, symptoms scoring index IPSS reduced from 21.0 to 11.71 (p<0.05). The flow of urinary increased from 4.56ml/s to 8.98ml/s (p<0.05). Residual urine volume reduced from 16.52ml to 8.35ml (p<0.05). The therapeutic outcomes by the extract of "Than khi hoan gia giam" were classified as follows: Good in 23 cases (54.8%), Moderate in 15 cases (35.7%), Poor in 4 cases (9.5%).
Prostatic Hyperplasia
;
Therapeutics
;
Prostatic Hyperplasia
;
Medicine, Traditional
6.The Comparative Study of Interstitial Laser Coagulation and Transurethral Resection for Begin Prostatic Hyperplasia.
Ja Hwan KOO ; Seong CHOI ; Hyun Yul RHEW
Korean Journal of Urology 2000;41(9):1125-1130
No abstract available.
Laser Coagulation*
;
Prostatic Hyperplasia*
7.Induction of Prostate Apoptosis by Low Dose Terazosin in Benign Prostatic Hyperplasia.
Seong Soo JEON ; Il Mo KANG ; Jeong Hee HONG ; Eun Kyung BAE ; Soo Eung CHAI ; Han Yong CHOI
Korean Journal of Urology 2000;41(9):1051-1056
No abstract available.
Apoptosis*
;
Prostate*
;
Prostatic Hyperplasia*
8.Clinical Effect of Prazosin Hydrochloride in Patient with Benign Prostatic Hypertrophy.
Korean Journal of Urology 1989;30(4):509-513
The clinical effect of prazosin, an alpha-1-receptor blocking agent, was studied in 31 patients with benign prostatic hypertrophy. The daily dose of 1.5-6 mg of prazosin was given for 2 weeks to 3 months. The efficacy was assessed by using uroflowmetry calculated from maximum flow rate, average flow rate and residual urine volume. The result revealed significant improvement of day time frequency, night time frequency (p<0.05) and maximum and average flow rate (p<0.05). It was suspected that prazosin was the valuable alpha-1-receptor blocker for benign prostatic hypertrophy and worth while to initiate medical treatment before undergoing any surgical intervention or when surgery is contraindicated.
Humans
;
Prazosin*
;
Prostatic Hyperplasia*
9.Male Sexual Dysfunction Associated with the Treatment for Benign Prostatic Hyperplasia.
Jae Seung PAICK ; Soo Woong KIM
Korean Journal of Andrology 1998;16(2):121-128
No abstract available.
Humans
;
Male*
;
Prostatic Hyperplasia*
10.Contact Laser Induced Prostatectomy: Preliminary Experience.
Woo chul MOON ; Bo sang NO ; Sun kyu LEE
Korean Journal of Urology 1995;36(5):507-517
No abstract available.
Prostatectomy*
;
Prostatic Hyperplasia
Result Analysis
Print
Save
E-mail